Facial Injectable Market Size Worth $33.63 Billion By 2032 | CAGR: 12.6%

The global facial injectable market size is expected to reach USD 33.63 billion by 2032, according to a new study by Polaris Market Research. The report “Global Facial Injectable Market Share, Size, Trends, Industry Analysis Report: Information By Product, By Application, By End-Use (MedSpa, Dermatology Clinics, Hospitals), And By Region (North America, Europe, Asia-Pacific, Middle East & Africa, And Latin America) – Market Forecast, 2024 - 2032.” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The demand for facial injectables is rapidly increasing due to the introduction of cost-effective procedures that have significantly expanded the market's demand. Products offer accessible options for consumers seeking aesthetic enhancements without high costs, thus widening the customer base and increasing overall market penetration.

Moreover, the growing demand for facial injectables is driven by increased regulatory approvals, that ensures safety, effectiveness and make treatments more accessible and appealing to a broader range of consumers. For instance, in May 2023, AbbVie announced the FDA approval of Juvederm's Skinvive to improve skin smoothness in the cheeks. This approval emphasizes the growing acceptance and innovation in facial injectables, driving market growth and enhancing consumer confidence in treatments.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/global-facial-injectable-market/request-for-sample

Furthermore, the overall number of cosmetic procedures, including facial injectables, continues to rise steadily, in turn driving the market revenue. For instance, according to the American Society of Plastic Surgeons (ASPS), in 2022, the United States witnessed 26.2 million surgical and minimally invasive cosmetic procedures, observing a 19% increase since 2019. This rising trends for surgical and minimally invasive cosmetic procedures are driven by advancements in medical technology and improved safety profiles of injectable products. The combination of these factors creates a synergistic effect, boosting demand within the facial injectables market. 

Facial Injectable Market Report Highlights

• The hyaluronic acid (HA) segment held the largest market share in 2023 due to its widespread adoption for effective cosmetic enhancements.
• The lip augmentation is expected to grow fastest over the forecast period, driven by consumer demand for fuller lips, advanced techniques, and diverse product options.
• North America was the dominant region in the global facial injectables market in 2023, experiencing significant growth in cosmetic procedures due to non-invasive treatments and product innovations.
• The global key market players include Allergan Aesthetics (AbbVie), BIOPLUS CO., LTD., Bioxis Pharmaceuticals, GALDERMA, Ipsen Pharma, Merz Pharma, Medytox, Prollenium Medical Technologies, SINCLAIR PLASTIC SURGERY, and Teoxane

Polaris Market Research has segmented the facial injectable market report based on product, application, end-use and region:

Facial Injectable, Product Outlook (Revenue - USD Billion, 2019 - 2032)

• Collagen & PMMA Microspheres
• Botulinum Toxin Type A
• Hyaluronic Acid (HA)
• Calcium Hydroxylapatite (CaHA)
• Poly-L-lactic Acid (PLLA)
• Others

Facial Injectable, Application Outlook (Revenue - USD Billion, 2019 - 2032)

• Facial Line Correction
• Lip Augmentation
• Face Lift
• Acne Scar Treatment
• Lipoatrophy Treatment
• Others

Facial Injectable, End-Use (Revenue - USD Billion, 2019 - 2032)

• MedSpa
• Dermatology Clinics
• Hospitals

Facial Injectable, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

• North America

• U.S.
• Canada

• Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe

• Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Australia
• Malaysia
• Rest of Asia Pacific

• Latin America

• Argentina
• Brazil
• Mexico
• Rest of Latin America

• Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of Middle East & Africa

Facial Injectable Report Scope: